PuSH - Publication Server of Helmholtz Zentrum München

Ribi, S.* ; Baumhoer, D. ; Lee, K.* ; Edison* ; Teo, A.S.* ; Madan, B.* ; Zhang, K.* ; Kohlmann, W.K.* ; Yao, F.* ; Lee, W.H.* ; Hoi, Q.* ; Cai, S.W.* ; Woo, X.Y.* ; Tan, P.L.* ; Jundt, G.* ; Smida, J. ; Nathrath, M. ; Sung, W.K.* ; Schiffman, J.D.* ; Virshup, D.M.* ; Hillmer, A.M.*

TP53 intron 1 hotspot rearrangements are specific to sporadic osteosarcoma and can cause Li-Fraumeni syndrome.

Oncotarget 6, 7727-7740 (2015)
Publ. Version/Full Text DOI PMC
Free by publisher
Creative Commons Lizenzvertrag
Somatic mutations of TP53 are among the most common in cancer and germline mutations of TP53 (usually missense) can cause Li-Fraumeni syndrome (LFS). Recently, recurrent genomic rearrangements in intron 1 of TP53 have been described in osteosarcoma (OS), a highly malignant neoplasm of bone belonging to the spectrum of LFS tumors. Using whole-genome sequencing of OS, we found features of TP53 intron 1 rearrangements suggesting a unique mechanism correlated with transcription. Screening of 288 OS and 1,090 tumors of other types revealed evidence for TP53 rearrangements in 46 (16%) OS, while none were detected in other tumor types, indicating this rearrangement to be highly specific to OS. We revisited a four-generation LFS family where no TP53 mutation had been identified and found a 445 kb inversion spanning from the TP53 intron 1 towards the centromere. The inversion segregated with tumors in the LFS family. Cancers in this family had loss of heterozygosity, retaining the rearranged allele and resulting in TP53 expression loss. In conclusion, intron 1 rearrangements cause p53-driven malignancies by both germline and somatic mechanisms and provide an important mechanism of TP53 inactivation in LFS, which might in part explain the diagnostic gap of formerly classified "TP53 wild-type" LFS.
Altmetric
Additional Metrics?
[➜Log in]
Edit extra informations Login
Publication type Article: Journal article
Document type Scientific Article
Corresponding Author
Keywords Tp53 ; Li-fraumeni Syndrome ; Osteosarcoma ; Cancer Genomics ; Structural Variations; P53 Isoforms; Genomic Rearrangements; Structural Variations; Lynch Syndrome; Cancer; Gene; Cells; Transcript; Families; Delta-133p53
ISSN (print) / ISBN 1949-2553
e-ISSN 1949-2553
Journal OncoTarget
Quellenangaben Volume: 6, Issue: 10, Pages: 7727-7740 Article Number: , Supplement: ,
Publisher Impact Journals LLC
Non-patent literature Publications
Reviewing status Peer reviewed
Institute(s) CCG Osteosarcoma (PATH-KOS)
Institute of Radiation Biology (ISB)
Institute of Pathology (PATH)